ArticleBMC public health2026
Examining a multicomponent health promotion intervention among Black same gender loving men in southern ending the HIV epidemic in the U.S. jurisdictions: a randomized controlled trial.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06315218 (Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
This protocol describes a hybrid type 2 effectiveness-implementation trial to examine the effectiveness, maintenance, and reach of an mHealth-mediated intervention to promote HIV and psychological health among Black same gender loving men. The intervention was developed by and for Black same gender loving men and seeks to reduce social isolation, increase access to culturally affirming healthcare, and decrease barriers to stable housing and economic empowerment due to interpersonal, institutional, and structural stigma. It does so through promoting individual-level health education and motivation, social support among Black same gender loving men, access to culturally-affirming healthcare, and pathways to stable housing and economic empowerment. This study will be implemented in the Ending the HIV Epidemic in the U.S. jurisdictions in and around Atlanta, GA through a collaboration between NAESM, a Black same gender loving men-led community-based organization in Atlanta, GA, Positive Impact Health Centers, an Atlanta-based comprehensive HIV service organization, and Rutgers School of Public Health in New Jersey. This study will test the latest iteration of the intervention called NPOWER365. We will conduct a 6-month randomized controlled trial to assess the effectiveness of NPOWER365 on HIV-related and psychological health, its moderating effect on intersectional stigma, and its intervention maintenance and reach. We will randomize 350 Black same gender loving men living with HIV to intervention (n = 175) or wait-list control (n = 175) groups and assess daily and longer-lag HIV care (i.e., anti-retroviral treatment adherence) and psychological health (e.g., depressive symptoms, anxiety symptoms) outcomes through baseline and 6-month daily diary studies and 1-, 2-, 4-, and 6-month longer-lag assessments. We will analyze intervention effectiveness, stigma moderation, and implementation outcome data through dynamic structural equation modelling and latent growth curve models. Thus, this study will establish the effectiveness of NPOWER365, a community-led mHealth intervention, for improving HIV behavioral and psychological health for Black same gender loving men living with HIV in four of the Ending the HIV Epidemic jurisdictions with the highest HIV burden. NPOWER365 was designed for implementation and is poised to offer a model for effective HIV and psychological support among Black SGLM in high-stigma, low-resource areas of the U.S. South and beyond. This trial is registered on ClinicalTrials.gov (NCT06315218).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.